The Irish Times

Pfizer and Mylan to combine off-patent drugs businesses

Deal between makers of EpiPens and Viagra will create group with global annual revenues worth €18bn

Mon Jul 29 2019 - 18:18

Pfizer expected to announce stock deal with Mylan

Deal would cover former blockbuster brands like Lipitor and Viagra, both made in Ireland

Sun Jul 28 2019 - 13:38

Perrigo pays executives bonuses for fending off Mylan offers

Dublin-based drugmaker’s chief executive Joe Papa receives additional stock and bonus

Wed Mar 09 2016 - 09:01

Mylan admits that bid for Dublin-based Perrigo has failed

Drugmaker said it fell short of 50% share threshold in tender offer

Fri Nov 13 2015 - 14:19

Perrigo fails in bid to block Mylan’s Israeli stock listing

Court rules against Dublin-based pharma company’s attempt to halt Tel Aviv listing

Thu Oct 29 2015 - 10:02

Cantillon: Don’t expect dividends in Mylan offer

The company looking to buy Perrigo has a stated policy of not paying dividends

Tue Sept 15 2015 - 01:00

Mylan to ask Perrigo shareholders to accept $27.1bn takeover

Dublin-based Perrigo’s board have previously refused bid

Tue Sept 08 2015 - 14:33

Mylan and Perrigo each win backing in hostile takeover battle

Proxy advisor ISS says bid for Dublin-based Perrigo too expensive, but Mylan investor and hedge fund Paulson

Sun Aug 16 2015 - 17:32

Mylan defends way it saw off hostile takeover

Chief executive says shareholders can go elsewhere if not happy

Fri Aug 07 2015 - 01:00

Drug firm Perrigo buys OTC portfolio of drugs from GSK

Bolt-on acqusition strengthens position in Europe amid three-way takeover battle

Tue Jun 02 2015 - 19:34

Generic drugmaker Teva makes $40bn offer for rival Mylan

Mylan adopts poison-pill defence and renews commitment to Perrigo deal

Wed Apr 22 2015 - 01:00

Cantillon: Perrigo at wrong end of another deal

Perrigo chief executive Joe Papa and Mylan chairman Robert Coury talking about merger for some time

Sat Apr 11 2015 - 02:22

Generics group Mylan swoops on rival Perrigo with $28.9bn deal

Surprise bid signals reluctance of Perrigo to agree friendly merger in behind the scenes dialogue and continues record period of pharma sector consolidation

Wed Apr 08 2015 - 20:28